Pardes Biosciences
Laura is an experienced professional with years of expertise in global commercial operations and strategic planning. Her career history spans decades and has included diverse roles, including Executive Vice President, Worldwide Commercial Operations at Gilead Sciences. Laura also worked in various roles at Amgen, including Senior Vice President, U.S Commercial Operations. She currently serves on the board of directors of numerous companies, including Anaptysbio, Y-mAbs Therapeutics, and Scilex Holding Company.
Laura holds a BS in Business Administration from the University of Arizona.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Pardes Biosciences
Pardes Biosciences is an agile biopharmaceutical company committed to solving some of the world’s most pressing public health challenges. Pardes leverages structure-based drug design and a tunable, reversible covalent chemistry platform for novel drug discovery.